BERLIN, GERMANY, October 05, 2013 /24-7PressRelease/
-- MediPurpose(tm), a master distributor and manufacturer of medical products, today announced an addition to its expanding portfolio of lancet patents.
The medical product company was recently granted patent 6009016940.8 for its babyLance(tm) safety heelstick from the German Patent and Trade Mark Office (DPMA) in Berlin, Germany.
The German patent grant validates babyLance's recent European Patent Office (EPO) patent application approval. Although an EPO patent provides intellectual property protection in the EPO's 38 member states, country-specific validation extends the patent's protective effect and enforceability.
The babyLance EPO patent 2303123 is awaiting validation in other EPO member states.
About babyLance Safety Heelsticks
babyLance safety heelsticks are single-use safety needlestick devices for the collection of blood from infants.
After investing more than a year in its redesign, MediPurpose launched the all-new babyLance in August 2012.
babyLance is available in two models, each with a specific blade penetration:
* babyLance BLP (preemie): 0.85 mm depth
* babyLance BLN (newborn): 1.0 mm depth
Specifically designed to meet end-user expectations for the ideal heelstick, the new babyLance provides enhanced stability, comfort and ease of use.
For more information about babyLance safety heelsticks -- including no-cost product sample requests -- please visit http://www.medipurpose.com/babylance
Founded in 1999, MediPurpose is an innovative medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance safety heelstick, SurgiLance safety lancet and MediPlus advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.
For more information about MediPurpose's medical products please visit http://www.medipurpose.com